OTC Simvastatin In UK Will Provide Boon For Rx Counterparts – Lancet Letter
This article was originally published in The Tan Sheet
Executive Summary
An Rx-to-OTC switch of 10 mg simvastatin is "not guaranteed" to take pressure off government health expenditures in the UK, according to a letter to the editor in the July 31 Lancet
You may also be interested in...
UK Public “Experiment” With OTC Zocor Challenged In Lancet Editorial
Editors of the UK medical journal The Lancet suggest that a surveillance system be put in place to monitor use of OTC simvastatin in an editorial appearing in the journal's May 22 issue
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands